Zanaflex
NDC 70515-604, tizanidine hydrochloride, capsule, from Covis Pharma US, Inc.
- Product NDC
- 70515-604
- Status
- Listed
- Labeler
- Covis Pharma US, Inc
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021447
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70515-604 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIZANIDINE HYDROCHLORIDE4 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70515-604-15 | 70515060415 | 150 CAPSULE in 1 BOTTLE (70515-604-15) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/043d9e51-bfa2-4add-9058-5ece332f7e99
Use it
Look up 70515-604 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70515-604 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70515-604. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.